Nemaura Medical Top Management

NMRDDelisted Stock  USD 0.08  0.01  12.09%   
Nemaura Medical employs about 36 people. The company is managed by 15 executives with a total tenure of roughly 50 years, averaging almost 3.0 years of service per executive, having 2.4 employees per reported executive. Evaluation of Nemaura Medical's management performance can provide insight into the firm performance.
Dewan Chowdhury  Chairman
Chairman of the Board and Presidentident, CEO
Chris Avery  President
Vice President - Global Business Operations
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Nemaura Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.4928) % which means that it has lost $0.4928 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.2444) %, meaning that it created substantial loss on money invested by shareholders. Nemaura Medical's management efficiency ratios could be used to measure how well Nemaura Medical manages its routine affairs as well as how well it operates its assets and liabilities.

Nemaura Medical Workforce Comparison

Nemaura Medical is rated below average in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 5,181. Nemaura Medical maintains roughly 36.0 in number of employees contributing less than 1% to equities under Health Care industry.

Nemaura Medical Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nemaura Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nemaura Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nemaura Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nemaura Medical Notable Stakeholders

A Nemaura Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nemaura Medical often face trade-offs trying to please all of them. Nemaura Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nemaura Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dewan ChowdhuryChairman of the Board and Presidentident, CEOProfile
Chris AveryVice President - Global Business OperationsProfile
Iain AndersonCFOProfile
Kathryn FarrarDirector of FinanceProfile
Salim NathaIndependent DirectorProfile
Timothy JohnsonIndependent DirectorProfile
David ScottDirector of Commercial Development and LicensingProfile
Karrar KhanDirector of Product DevelopmentProfile
Thomas MooreIndependent DirectorProfile
Bashir TimolChief DirectorProfile
Arash GhadarChief OfficerProfile
Samantha SandersGlobal ProgramsProfile
Richard ToonBusiness and Technical Development ManagerProfile
Jay WarnerHead OperationsProfile
Thomas MortensenHead MarketingProfile

About Nemaura Medical Management Performance

The success or failure of an entity such as Nemaura Medical often depends on how effective the management is. Nemaura Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nemaura management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nemaura management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.
The data published in Nemaura Medical's official financial statements usually reflect Nemaura Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nemaura Medical. For example, before you start analyzing numbers published by Nemaura accountants, it's critical to develop an understanding of what Nemaura Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Nemaura Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nemaura Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nemaura Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nemaura Medical. Please utilize our Beneish M Score to check the likelihood of Nemaura Medical's management manipulating its earnings.

Nemaura Medical Workforce Analysis

Traditionally, organizations such as Nemaura Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nemaura Medical within its industry.

Nemaura Medical Manpower Efficiency

Return on Nemaura Medical Manpower

Revenue Per Employee2.1K
Revenue Per Executive5.1K
Net Loss Per Employee392.9K
Net Loss Per Executive942.9K
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Nemaura Stock

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets